1. Home
  2. Clinical White Papers

Clinical White Papers

Get to know a gene: CES1A1

Summary: CES1A1 is the primary enzyme responsible for the metabolism of methylphenidate (MPH).1 The Gly143Glu polymorphism reduces enzyme activity, which could result in elevated plasma concentrations of some parent compounds…
Read More

The GeneSight® Psychotropic Combinatorial Algorithm

The Pharmacogenomic (PGx) Algorithm: A common discussion among experts revolves around pharmacogenomic (PGx) testing algorithms. Many commercial tests are proprietary, and therefore, their algorithms are considered a “black box”.1 This…
Read More

GET TO KNOW A GENE: HLA-B*1502 and HLA-A*3101

Summary: The human leukocyte antigen (HLA) complex plays an important role in immune regulation. HLA-B*1502 has demonstrated the ability to predict an increased risk of severe skin reactions, such as Stevens-Johnsons…
Read More

Get to know a gene: CACNA1C

Summary: Minimal evidence exists linking CACNA1C as a pharmacogenomic marker, and CACNA1C shows little clinical utility as a disease marker. While there is an association between CACNA1C and bipolar disorder…
Read More

How Do I Use the Gene-Drug Interaction Chart?

What is the gene-drug interaction chart? Healthcare providers and patients often inquire about how they can determine which genes may affect outcomes with each medication. The gene-drug interaction chart provides…
Read More

Get to know a gene: ANK3

Summary: ANK3 has not been shown to inform on patient medication response and therefore is not a pharmacogenomic marker. As a disease marker, it lacks clinical utility. There is an…
Read More

Get to know a gene: COMT

Summary: The Val158Met polymorphism (rs4680) in the COMT gene can affect baseline levels of synaptic catecholamines. Several studies have assessed the impact of this polymorphism on treatment outcomes with psychotropic…
Read More
Menu